GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Pretax Margin %

Veracyte (FRA:12V) Pretax Margin % : -31.03% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Veracyte's Pre-Tax Income for the three months ended in Dec. 2023 was €-27.9 Mil. Veracyte's Revenue for the three months ended in Dec. 2023 was €90.0 Mil. Therefore, Veracyte's pretax margin for the quarter that ended in Dec. 2023 was -31.03%.

The historical rank and industry rank for Veracyte's Pretax Margin % or its related term are showing as below:

FRA:12V' s Pretax Margin % Range Over the Past 10 Years
Min: -76.91   Med: -33.46   Max: -10.47
Current: -21.22


FRA:12V's Pretax Margin % is ranked worse than
54.87% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.495 vs FRA:12V: -21.22

Veracyte Pretax Margin % Historical Data

The historical data trend for Veracyte's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veracyte Pretax Margin % Chart

Veracyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.47 -29.71 -37.20 -12.28 -21.22

Veracyte Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.28 -9.82 -9.16 -33.04 -31.03

Competitive Comparison of Veracyte's Pretax Margin %

For the Diagnostics & Research subindustry, Veracyte's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veracyte's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Veracyte's Pretax Margin % falls into.



Veracyte Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Veracyte's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-70.253/331.084
=-21.22 %

Veracyte's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-27.943/90.048
=-31.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veracyte  (FRA:12V) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Veracyte Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Veracyte's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veracyte (FRA:12V) Business Description

Traded in Other Exchanges
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines